Biodexa Pharmaceuticals (BDRX) Accounts Payables (2013 - 2026)
Biodexa Pharmaceuticals (BDRX) reported Accounts Payables of $2.19 million for the quarter ended Jun 30, 2026, up 16.4% from $1.89 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Accounts Payables (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals posted Accounts Payables of $3.41 million, down 23.8% from the prior year.
- Accounts Payables has a five-year compound annual growth rate of 16.7% (years ended Dec 2020 to Dec 2025).
- By year, Accounts Payables came in at $4.48 million in the year ended Dec 31, 2024 (+190.4%), $1.54 million in the year ended Dec 31, 2023 (-13.9%), $1.79 million in the year ended Dec 31, 2022 (+19.2%) and $1.5 million in the year ended Dec 31, 2021 (-4.9%).
- Five-year quarterly Accounts Payables spans a low of $1.47 million in the quarter ended Dec 31, 2021 and a high of $4.5 million in the quarter ended Dec 31, 2024.
- Year over year, Accounts Payables gained in two of the last four quarters, with growth averaging 43.4%.
- The high point for year-over-year Accounts Payables in five years was the quarter ended Dec 31, 2024 (growth of 192.2%); the low point was the quarter ended Jun 30, 2022 (a decline of 43.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Biodexa Pharmaceuticals | 4,123.69 | -23.40 Mn | - | 2.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Dec 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Jun 30, 2021 | 2.82 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Jun 30, 2020 | 3.43 Mn |
| Dec 31, 2019 | 5.89 Mn |
| Jun 30, 2019 | 3.20 Mn |
| Dec 31, 2018 | 2.67 Mn |
| Jun 30, 2018 | 4.50 Mn |
| Dec 31, 2017 | 10.76 Mn |
| Jun 30, 2017 | 8.65 Mn |
| Dec 31, 2016 | 10.33 Mn |
| Jun 30, 2016 | 7.80 Mn |
API Access
Biodexa Pharmaceuticals Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();